Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, McGill Reproductive Centre, McGill University, Montreal, Quebec, Canada.
Gynecol Endocrinol. 2011 Nov;27(11):876-9. doi: 10.3109/09513590.2011.569596. Epub 2011 Apr 15.
The aim of this retrospective study was to compare the oocyte yield with the luteal estradiol patch (LPA) - GnRH antagonist and microdose (MD) flare-up protocols in anticipated poor responders. Fifty-seven women who underwent IVF treatment following stimulation with LPA or MD protocols at McGill Reproductive Centre were matched for age and markers of ovarian reserve. Numbers of oocytes collected (6 vs 7), mature oocytes collected (5 vs 5), and oocyte maturation rates (72% vs 74%) were similar. The numbers of good quality embryos available (2 vs 1) and embryos transferred (3 vs 3) were likewise similar. Embryo implantation rate of 16.7% and clinical pregnancy rate of 38.9% achieved in the LPA group were almost 50% higher than the corresponding figures at 10.3% and 22.2% in the MD group; however, the differences were not statistically significant (p > 0.05 for all comparisons). Although the results do not suggest an increased oocyte yield or follicular synchronization with the LPA protocol, the observed trend toward higher embryo implantation and clinical pregnancy rates requires further research.
本回顾性研究旨在比较黄体生成素释放激素拮抗剂(GnRH antagonist)和微刺激(MD)爆发方案与卵巢储备不良患者的获卵数。在麦吉尔生殖中心,对接受黄体生成素释放激素拮抗剂或 MD 方案刺激的 57 名 IVF 治疗患者进行了匹配,比较了年龄和卵巢储备标志物。收集的卵母细胞数量(6 个对 7 个)、成熟卵母细胞数量(5 个对 5 个)和卵母细胞成熟率(72%对 74%)相似。可用的优质胚胎数量(2 个对 1 个)和胚胎移植数量(3 个对 3 个)也相似。黄体生成素释放激素拮抗剂组的胚胎着床率为 16.7%,临床妊娠率为 38.9%,几乎比 MD 组的 10.3%和 22.2%高 50%;然而,差异无统计学意义(所有比较的 p > 0.05)。虽然结果并未表明黄体生成素释放激素拮抗剂方案可增加获卵数或卵泡同步性,但观察到胚胎着床和临床妊娠率升高的趋势需要进一步研究。